Renalytix Historical Income Statement

RNLX Stock  USD 0.16  0.01  6.67%   
Historical analysis of Renalytix income statement accounts such as Interest Income of 556.1 K, Depreciation And Amortization of 309.6 K, Selling General Administrative of 18.7 M or Total Revenue of 1.9 M can show how well Renalytix AI performed in making a profits. Evaluating Renalytix income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Renalytix's future profits or losses.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Renalytix AI latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Renalytix AI is a good buy for the upcoming year.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Renalytix AI. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

About Renalytix Income Statement Analysis

Renalytix AI Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Renalytix shareholders. The income statement also shows Renalytix investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Renalytix Income Statement Chart

At this time, Renalytix's Interest Expense is fairly stable compared to the past year. Tax Provision is likely to rise to 4,200 in 2024, whereas Other Operating Expenses is likely to drop slightly above 29.8 M in 2024.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Renalytix AI. It is also known as Renalytix overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Cost Of Revenue

Cost of Revenue is found on Renalytix AI income statement and represents the costs associated with goods and services Renalytix provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.
Most accounts from Renalytix's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Renalytix AI current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Renalytix AI. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
At this time, Renalytix's Interest Expense is fairly stable compared to the past year. Tax Provision is likely to rise to 4,200 in 2024, whereas Other Operating Expenses is likely to drop slightly above 29.8 M in 2024.
 2021 2022 2023 2024 (projected)
Total Operating Expenses58.3M43.1M29.0M33.2M
Cost Of Revenue2.1M2.7M2.1M1.4M

Renalytix income statement Correlations

-1.00.10.560.69-0.60.670.92-0.99-0.98-0.79-1.00.910.99-0.18-0.990.12-0.980.1
-1.0-0.07-0.51-0.650.62-0.67-0.920.990.980.81.0-0.91-0.990.20.99-0.080.98-0.07
0.1-0.070.530.260.120.37-0.13-0.12-0.080.08-0.080.340.120.27-0.090.12-0.091.0
0.56-0.510.530.95-0.140.130.49-0.59-0.4-0.21-0.530.430.58-0.14-0.450.78-0.410.53
0.69-0.650.260.95-0.220.110.68-0.72-0.54-0.32-0.670.480.71-0.29-0.590.78-0.550.26
-0.60.620.12-0.14-0.22-0.44-0.410.560.590.950.59-0.5-0.560.20.590.130.590.12
0.67-0.670.370.130.11-0.440.55-0.65-0.74-0.58-0.670.850.650.45-0.72-0.39-0.740.37
0.92-0.92-0.130.490.68-0.410.55-0.93-0.89-0.6-0.930.780.93-0.09-0.910.23-0.89-0.13
-0.990.99-0.12-0.59-0.720.56-0.65-0.930.970.751.0-0.91-1.00.20.99-0.150.97-0.12
-0.980.98-0.08-0.4-0.540.59-0.74-0.890.970.790.98-0.95-0.970.171.00.081.0-0.08
-0.790.80.08-0.21-0.320.95-0.58-0.60.750.790.78-0.71-0.750.260.790.170.790.08
-1.01.0-0.08-0.53-0.670.59-0.67-0.931.00.980.78-0.91-1.00.190.99-0.10.98-0.08
0.91-0.910.340.430.48-0.50.850.78-0.91-0.95-0.71-0.910.9-0.01-0.94-0.14-0.950.34
0.99-0.990.120.580.71-0.560.650.93-1.0-0.97-0.75-1.00.9-0.2-0.990.15-0.980.12
-0.180.20.27-0.14-0.290.20.45-0.090.20.170.260.19-0.01-0.20.18-0.120.180.27
-0.990.99-0.09-0.45-0.590.59-0.72-0.910.991.00.790.99-0.94-0.990.180.021.0-0.09
0.12-0.080.120.780.780.13-0.390.23-0.150.080.17-0.1-0.140.15-0.120.020.070.12
-0.980.98-0.09-0.41-0.550.59-0.74-0.890.971.00.790.98-0.95-0.980.181.00.07-0.09
0.1-0.071.00.530.260.120.37-0.13-0.12-0.080.08-0.080.340.120.27-0.090.12-0.09
Click cells to compare fundamentals

Renalytix Account Relationship Matchups

Renalytix income statement Accounts

201920202021202220232024 (projected)
Other Operating Expenses11.1M34.1M60.3M45.8M31.2M29.8M
Ebit(11.1M)(34.0M)(53.2M)(42.2M)(28.9M)(30.3M)
Net Income Applicable To Common Shares(9.3M)(34.7M)(45.3M)(45.6M)(41.0M)(39.0M)
Tax Provision(1.4M)(4.8M)25K2K4K4.2K
Net Interest Income531K(3.0M)9.6M509K585.4K556.1K
Interest Income194K236K9.6M509K585.4K556.1K
Depreciation And Amortization(485K)282K489K508K364K309.6K
Selling General Administrative11.1M8.4M13.0M43.1M19.8M18.7M
Gross Profit(74K)687K918K701K156K148.2K
Operating Income(11.1M)(32.6M)(57.4M)(42.4M)(29.6M)(31.1M)
Net Income From Continuing Ops(9.3M)(35.3M)(45.3M)(46.2M)(33.5M)(35.1M)
Research Development4.6M10.0M14.6M14.3M9.3M12.3M
Ebitda(11.6M)(33.7M)(52.7M)(41.7M)(28.5M)(29.9M)
Cost Of Revenue74K804K2.1M2.7M2.1M1.4M
Total Operating Expenses11.1M33.3M58.3M43.1M29.0M33.2M
Reconciled Depreciation1.2M282K489K2.5M364K345.8K
Income Before Tax(10.6M)(35.8M)(49.6M)(46.2M)(33.5M)(35.1M)
Total Other Income Expense Net468K(2.1M)7.9M(3.4M)(3.8M)(3.7M)
Net Income(9.3M)(34.7M)(45.3M)(45.6M)(33.5M)(35.1M)
Income Tax Expense(1.4M)(4.8M)25K2K4K4.2K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Renalytix Stock Analysis

When running Renalytix's price analysis, check to measure Renalytix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Renalytix is operating at the current time. Most of Renalytix's value examination focuses on studying past and present price action to predict the probability of Renalytix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Renalytix's price. Additionally, you may evaluate how the addition of Renalytix to your portfolios can decrease your overall portfolio volatility.